CHEK2 is associated with Li-Fraumeni syndrome, an autosomal dominant disorder that manifests as multiple malignancies, including soft tissue sarcomas and breast cancer, supporting causality [37]. The gene discussed is CHEK2; the disease is Li-Fraumeni syndrome.